Publicaciones en colaboración con investigadores/as de University of Melbourne (6)

2023

  1. Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours

    Nature Reviews Clinical Oncology, Vol. 20, Núm. 6, pp. 372-389

2022

  1. Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer

    New England Journal of Medicine, Vol. 387, Núm. 3, pp. 217-226

2021

  1. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    npj Breast Cancer, Vol. 7, Núm. 1

2020

  1. Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study

    Annals of Oncology, Vol. 31, Núm. 5, pp. 569-581

2017

  1. Research needs in breast cancer

    Annals of Oncology, Vol. 28, Núm. 2, pp. 208-217

  2. Tumor-infiltrating lymphocytes in Breast Cancer and implications for clinical practice

    Biochimica et Biophysica Acta - Reviews on Cancer, Vol. 1868, Núm. 2, pp. 527-537